Crossmark

Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence

Crossref DOI link: https://doi.org/10.1007/s40264-018-0653-3

Published Online: 2018-03-20

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Saucier, Roxanne

Wolfe, Daniel

Dasgupta, Nabarun http://orcid.org/0000-0002-4098-605X
Funding

Funding for this research was provided by:

Open Society Foundations
License Information

Text and Data Mining valid from 2018-03-20
More Information

Article History

First Online: 20 March 2018

Change Date: 24 May 2018

Change Type: Correction

Change Details: Introduction 3rd Paragraph.

Compliance with Ethical Standards

:

: This study was funded by Open Society Foundations.

: Daniel Wolfe is an employee of Open Society Foundations and Roxanne Saucier is a consultant to Open Society Foundations. Nabarun Dasgupta is a part-time employee of the RADARS System, which had no involvement in this study. The RADARS System is supported by subscriptions from pharmaceutical manufacturers, and governmental and non-governmental agencies for data, research, and reporting services. The RADARS System is the property of the Denver Health and Hospital Authority, a political subdivision of the State of Colorado (USA). Employees are prohibited from financial relationships with any biopharmaceutical company.

: All data used in this analysis were publicly available and redacted of identifying information by the US Food and Drug Administration, therefore no external institutional review board approval was needed.